Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer 01/08/2019 INTERVENTIONAL unchanged 2,787.85 0 A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer 01/09/2019 OBSERVATIONAL unchanged 2,786.85 0 Converting HR+ Breast Cancer Into an Individualized Vaccine 01/15/2019 INTERVENTIONAL unchanged 2,780.85 0 Mechanisms of Pregnancy Vascular Adaptations 01/16/2019 OBSERVATIONAL unchanged 2,779.85 0 Cognitive Training for Patients With Eating Disorders 01/17/2019 INTERVENTIONAL unchanged 2,778.85 0 Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO 01/24/2019 INTERVENTIONAL unchanged 2,771.85 0 Elevate! : An Elderly Breast Cancer Cohort Study 01/28/2019 OBSERVATIONAL unchanged 2,767.85 0 Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections 01/28/2019 INTERVENTIONAL unchanged 2,767.85 0 Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer 01/29/2019 INTERVENTIONAL unchanged 2,766.85 0 Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair 01/29/2019 INTERVENTIONAL unchanged 2,766.85 0 Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease 01/30/2019 INTERVENTIONAL unchanged 2,765.85 0 A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy 01/30/2019 INTERVENTIONAL unchanged 2,765.85 0 Bioimpedance In Pregnancy and Labour: A Fluid Balance Concept Study. 01/31/2019 OBSERVATIONAL unchanged 2,764.85 0 Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer 01/31/2019 INTERVENTIONAL unchanged 2,764.85 0 HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer 02/01/2019 INTERVENTIONAL unchanged 2,763.85 0 Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II 02/04/2019 INTERVENTIONAL unchanged 2,760.85 0 Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment 02/04/2019 INTERVENTIONAL unchanged 2,760.85 0 Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting 02/05/2019 INTERVENTIONAL unchanged 2,759.85 0 PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood 02/05/2019 INTERVENTIONAL unchanged 2,759.85 0 Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer 02/06/2019 INTERVENTIONAL unchanged 2,758.85 0 TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation 02/07/2019 INTERVENTIONAL unchanged 2,757.85 0 A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) 02/11/2019 INTERVENTIONAL unchanged 2,753.85 0 Body Fat as Determinant of Female Gonadal Dysfunction 02/15/2019 OBSERVATIONAL unchanged 2,749.85 0 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) 02/15/2019 INTERVENTIONAL unchanged 2,749.85 0 Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease 02/22/2019 INTERVENTIONAL unchanged 2,742.85 0 FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II) 02/26/2019 INTERVENTIONAL unchanged 2,738.85 0 A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine 02/26/2019 INTERVENTIONAL unchanged 2,738.85 0 Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele 02/27/2019 INTERVENTIONAL unchanged 2,737.85 0 Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer 02/27/2019 INTERVENTIONAL unchanged 2,737.85 0 Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET 03/01/2019 INTERVENTIONAL unchanged 2,735.85 0 SALpingectomy for STERilization (SALSTER) 03/04/2019 INTERVENTIONAL unchanged 2,732.85 0 Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening 03/05/2019 INTERVENTIONAL unchanged 2,731.85 0 Determining Prognostic Immune Markers in Patients With Ovarian Cancer 03/05/2019 OBSERVATIONAL unchanged 2,731.85 0 Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease 03/07/2019 INTERVENTIONAL unchanged 2,729.85 0 Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients 03/12/2019 INTERVENTIONAL unchanged 2,724.85 0 Best Start - Weight Management During Pregnancy 03/14/2019 INTERVENTIONAL unchanged 2,722.85 0 Transdermal Estrogen in Women With Anorexia Nervosa 03/14/2019 INTERVENTIONAL unchanged 2,722.85 0 Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: 03/14/2019 INTERVENTIONAL unchanged 2,722.85 0 Vaginal Native Tissues Repair for Pelvic Organ Prolapse 03/15/2019 INTERVENTIONAL unchanged 2,721.85 0 Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB) 03/15/2019 INTERVENTIONAL unchanged 2,721.85 0 Clinical Pre-screening Protocol for Ovarian Cancer 03/18/2019 OBSERVATIONAL unchanged 2,718.85 0 Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast 03/18/2019 INTERVENTIONAL unchanged 2,718.85 0 Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer 03/18/2019 INTERVENTIONAL unchanged 2,718.85 0 Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer 03/19/2019 INTERVENTIONAL unchanged 2,717.85 0 A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma 03/19/2019 INTERVENTIONAL unchanged 2,717.85 0 Sub-type Specific Genomic Mutations in sBOTs 03/21/2019 OBSERVATIONAL unchanged 2,715.85 0 Attitudes and Decision-making After Pregnancy Testing Study 03/25/2019 OBSERVATIONAL unchanged 2,711.85 0 Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer 03/27/2019 OBSERVATIONAL unchanged 2,709.85 0 Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy 03/27/2019 INTERVENTIONAL unchanged 2,709.85 0 Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry) 03/28/2019 OBSERVATIONAL unchanged 2,708.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology